Pancreatic endocrine tumors: Improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients

Aldo Scarpa, William Mantovani, Paola Capelli, Stefania Beghelli, Letizia Boninsegna, Rossella Bettini, Francesco Panzuto, Paolo Pederzoli, Gianfranco Delle Fave, Massimo Falconi

Research output: Contribution to journalArticle

Abstract

Pancreatic endocrine tumors are rare diseases and devising a clinically effective prognostic stratification of patients is a major clinical challenge. This study aimed at assessing whether the tumor-node-metastasis (TNM)-based staging and proliferative activity-based grading recently proposed by the European NeuroEndocrine Tumors Society (ENETS) have clinical value. TNM was applied to 274 patients with histologically diagnosed pancreatic endocrine tumors operated from 1991 to 2005, with last follow-up at December 2007. According to World Health Organization (WHO) classification, 246 were well-differentiated neoplasms (51 benign, 56 uncertain behavior, 139 carcinomas) and 28 poorly differentiated carcinomas. Grading was based on Ki67 immunohistochemistry. Survival analysis not only ascertained the prognostic value of the TNM system but also highlighted that in the absence of nodal and distant metastasis, infiltration and tumor dimensions over 4 cm had prognostic significance. T parameters were then appropriately modified to reflect this weakness. The 5-year survival for modified TNM stages I, II, III and IV were 100, 93, 65 and 35%, respectively. Multivariate analysis identified TNM stages as independent predictors of death, in which stages II, III and IV showed a risk of death of 7, 29 and 58 times higher than stage I tumors (P

Original languageEnglish
Pages (from-to)824-833
Number of pages10
JournalModern Pathology
Volume23
Issue number6
DOIs
Publication statusPublished - Jun 2010

Keywords

  • Endocrine
  • Grading
  • Pancreas
  • Prognosis
  • Staging
  • TNM
  • Tumors

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Pancreatic endocrine tumors: Improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients'. Together they form a unique fingerprint.

  • Cite this

    Scarpa, A., Mantovani, W., Capelli, P., Beghelli, S., Boninsegna, L., Bettini, R., Panzuto, F., Pederzoli, P., Fave, G. D., & Falconi, M. (2010). Pancreatic endocrine tumors: Improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Modern Pathology, 23(6), 824-833. https://doi.org/10.1038/modpathol.2010.58